Epstein–Barr virus status and immunosuppression use in paediatric autoimmune liver disease,Alimentary Pharmacology & Therapeutics

当前位置： X-MOL 学术 › Aliment. Pharm. Ther. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Epstein–Barr virus status and immunosuppression use in paediatric autoimmune liver disease
Alimentary Pharmacology & Therapeutics ( IF 6.6 ) Pub Date : 2021-11-18 , DOI: 10.1111/apt.16708
Jeremy S Nayagam _{1,

2} , Michael A Heneghan ₁ , Marianne Samyn ₃ , Deepak Joshi ₁

Affiliation

Since azathioprine is associated with lymphoproliferative disorders in Epstein–Barr virus (EBV)-naïve patients with inflammatory bowel disease, guidelines advise avoidance. No recommendations exist for autoimmune liver disease (AILD).

中文翻译：